• Something wrong with this record ?

Novel noninvasive biomarkers of prodromal Alzheimer disease: The role of optical coherence tomography and optical coherence tomography-angiography

L. Biscetti, M. Lupidi, E. Luchetti, P. Eusebi, R. Gujar, A. Vergaro, C. Cagini, L. Parnetti

. 2021 ; 28 (7) : 2185-2191. [pub] 20210430

Language English Country Great Britain

Document type Journal Article

BACKGROUND AND PURPOSE: A reduction of retinal thickness and an alteration of retinal perfusion have been found in Alzheimer disease (AD). Nowadays, retinal layers and retinal perfusion can be evaluated by means of noninvasive imaging techniques, namely, optical coherence tomography (OCT) and OCT-angiography (OCT-A). Here, we have compared the retinal thickness and the perfusion index, measured by means of OCT and OCT-A, in patients with mild cognitive impairment due to AD (MCI-AD) and in age- and sex-matched cognitively healthy controls. METHODS: Twenty-four MCI-AD patients and 13 control subjects were enrolled. MCI-AD patients underwent lumbar puncture; all of them showed a cerebrospinal fluid (CSF) profile compatible with AD. OCT was used for evaluating retinal volumes and thicknesses, whereas with OCT-A we measured fractal dimension (FD), vascular perfusion density (VPD), and vessel length density (VLD) of superficial capillary plexus (SCP), intermediate capillary plexus (ICP), deep capillary plexus (DCP), and choriocapillaris. The comparisons between groups were made after adjustment for age, diabetes, and hypertension. RESULTS: A significant reduction of SCP-VLD (p = 0.012), ICP-VPD (p = 0.015), ICP-VLD (p = 0.004), DCP-VPD (p = 0.012), and DCP-VLD (p = 0.009) was found in MCI-AD patients compared to controls. Conversely, FD was higher in MCI-AD than in controls (p = 0.044). CSF Aβ42/total tau negatively correlated with FD (r = -0.51, p = 0.010). CONCLUSIONS: OCT-A might have a potential role in detecting new noninvasive biomarkers for early AD detection. Retinal VPD might identify amyloid angiopathy-related chronic injury, and FD could show early vessel recruitment as a compensative mechanism at disease onset. Further studies will be needed to confirm these findings.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21025440
003      
CZ-PrNML
005      
20221021093733.0
007      
ta
008      
211013s2021 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/ene.14871 $2 doi
035    __
$a (PubMed)33852770
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Biscetti, Leonardo $u Section of Neurology, Laboratory of Clinical Neurochemistry, Department of Medicine and Surgery, University of Perugia, Perugia, Italy
245    10
$a Novel noninvasive biomarkers of prodromal Alzheimer disease: The role of optical coherence tomography and optical coherence tomography-angiography / $c L. Biscetti, M. Lupidi, E. Luchetti, P. Eusebi, R. Gujar, A. Vergaro, C. Cagini, L. Parnetti
520    9_
$a BACKGROUND AND PURPOSE: A reduction of retinal thickness and an alteration of retinal perfusion have been found in Alzheimer disease (AD). Nowadays, retinal layers and retinal perfusion can be evaluated by means of noninvasive imaging techniques, namely, optical coherence tomography (OCT) and OCT-angiography (OCT-A). Here, we have compared the retinal thickness and the perfusion index, measured by means of OCT and OCT-A, in patients with mild cognitive impairment due to AD (MCI-AD) and in age- and sex-matched cognitively healthy controls. METHODS: Twenty-four MCI-AD patients and 13 control subjects were enrolled. MCI-AD patients underwent lumbar puncture; all of them showed a cerebrospinal fluid (CSF) profile compatible with AD. OCT was used for evaluating retinal volumes and thicknesses, whereas with OCT-A we measured fractal dimension (FD), vascular perfusion density (VPD), and vessel length density (VLD) of superficial capillary plexus (SCP), intermediate capillary plexus (ICP), deep capillary plexus (DCP), and choriocapillaris. The comparisons between groups were made after adjustment for age, diabetes, and hypertension. RESULTS: A significant reduction of SCP-VLD (p = 0.012), ICP-VPD (p = 0.015), ICP-VLD (p = 0.004), DCP-VPD (p = 0.012), and DCP-VLD (p = 0.009) was found in MCI-AD patients compared to controls. Conversely, FD was higher in MCI-AD than in controls (p = 0.044). CSF Aβ42/total tau negatively correlated with FD (r = -0.51, p = 0.010). CONCLUSIONS: OCT-A might have a potential role in detecting new noninvasive biomarkers for early AD detection. Retinal VPD might identify amyloid angiopathy-related chronic injury, and FD could show early vessel recruitment as a compensative mechanism at disease onset. Further studies will be needed to confirm these findings.
650    12
$a Alzheimerova nemoc $x diagnostické zobrazování $7 D000544
650    _2
$a biologické markery $7 D015415
650    _2
$a fluoresceinová angiografie $7 D005451
650    _2
$a lidé $7 D006801
650    _2
$a retinální cévy $x diagnostické zobrazování $7 D012171
650    12
$a optická koherentní tomografie $7 D041623
655    _2
$a časopisecké články $7 D016428
700    1_
$a Lupidi, Marco $u Section of Ophthalmology, Department of Medicine and Surgery, University of Perugia, Perugia, Italy $u Macula Onlus Foundation, Di.N.O.G.Mi., University Eye Clinic, Genoa, Italy $u Odeon Center, Paris, France
700    1_
$a Luchetti, Elisa $u Section of Neurology, Laboratory of Clinical Neurochemistry, Department of Medicine and Surgery, University of Perugia, Perugia, Italy
700    1_
$a Eusebi, Paolo $u Section of Neurology, Laboratory of Clinical Neurochemistry, Department of Medicine and Surgery, University of Perugia, Perugia, Italy
700    1_
$a Gujar, Ramkailash $u Section of Ophthalmology, Department of Medicine and Surgery, University of Perugia, Perugia, Italy
700    1_
$a Vergaro, Andrea $u Department of Ophthalmology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic $7 xx0277880
700    1_
$a Cagini, Carlo $u Section of Ophthalmology, Department of Medicine and Surgery, University of Perugia, Perugia, Italy
700    1_
$a Parnetti, Lucilla $u Section of Neurology, Laboratory of Clinical Neurochemistry, Department of Medicine and Surgery, University of Perugia, Perugia, Italy
773    0_
$w MED00001629 $t European journal of neurology $x 1468-1331 $g Roč. 28, č. 7 (2021), s. 2185-2191
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33852770 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20211013 $b ABA008
991    __
$a 20221021093726 $b ABA008
999    __
$a ok $b bmc $g 1714475 $s 1145947
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 28 $c 7 $d 2185-2191 $e 20210430 $i 1468-1331 $m European journal of neurology $n Eur J Neurol $x MED00001629
LZP    __
$a Pubmed-20211013

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...